Advanced Enzyme Technologies Ltd Share Price

Pharmaceuticals

NSE: ADVENZYMES Small Cap ISIN: INE837H01020

As on 08 July 2025 at 01:47 IST

₹337.75

-0.50

(-0.15%)

Sell Buy

Over 1 Month

9.06%

Over 6 Months

-2.16%

Over 1 Year

-13.53%

Over 3 Years

23.72%

Advanced Enzyme Technologies Ltd Summary

Close ₹337.75

Open ₹339.20

High ₹345.15

Low ₹331.05

Volume 3,11,112

Net Turnover (in Cr) ₹10.55

52Wk High ₹571

52Wk Low ₹257.90

52Wk High / Low

257.90

571

Advanced Enzyme Technologies Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹3,778.79

EPS (TTM) 9.15

Book Value (BV) 56.25

Div. Yield 0.36 %

P/E (TTM) 36.91

Price/Book Value 6

Delivery % 40.89 %

Face Value 2

Key Ratios

PE Ratio 30.48

PB Ratio 4.96

EV to Sales 8.87

PEG Ratio -5.67

ROA 16.18

ROE 16.93

Debt-Equity -

Net Profit Margin 29.15

Operating Profit Margin 37.69

Advanced Enzyme Technologies Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	669.95	660.53	566.09	535.80	510.69
Total Expenses	482.59	457.58	421.64	364.75	300.56
Profit Before Tax	187.36	187.82	140.39	171.06	210.13
Profit After Tax	133.97	136.95	103.87	123.80	151.29
Operating Profit After Depreciation	190.92	205.88	146.87	172.85	211.74

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	678.69	660.11	654.94	624.55	609.56
Total Non Current Assets	741.48	725.72	699.74	663.17	640.16
Total Current Assets	879.87	809.74	722.11	604.44	516.01
Total Assets	1,621.35	1,535.46	1,421.85	1,267.61	1,156.17
Total Shareholder's Fund	1,420.86	1,324.13	1,235.07	1,088.59	970.94

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	142.50	141.37	140.36	122.29	162.97
Net Cash Used In Investing Activities	-89.48	-64.80	-285.50	1.65	-27.33
Net Cash Used In Financing Activities	-72.54	-59.24	-25.80	-48.50	-26.39

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	412.90	424.28	321.34	281.88	290.30
Total Expenses	292.37	271.34	247.06	209.81	191.87
Profit Before Tax	120.53	133.99	74.28	72.07	98.43
Profit After Tax	102.42	108.12	55.53	54.51	71.01
Operating Profit After Depreciation	120.76	153.10	74.41	72.17	98.53

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	156.52	147.54	148.28	137.46	137.60
Total Non Current Assets	456.43	384.59	386.26	352.94	329.37
Total Current Assets	232.20	248.34	189.54	176.69	160.23
Total Assets	688.63	632.93	575.80	529.62	489.60
Total Shareholder's Fund	629.34	580.47	525.33	480.35	435.45

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	63.48	51.63	50.30	37.10	84.23
Net Cash Used In Investing Activities	-1.74	-2.70	-42.35	-14.24	-69.91
Net Cash Used In Financing Activities	-57.63	-56.88	-11.99	-10.87	-15.49

Particulars (in ₹ Cr.)	2025-03	2024-12	2024-09	2024-06	2024-03
Total Revenue	167.18	169.11	146.10	154.52	157.82
Total Expenses	121.57	113.86	103.68	103.36	102.44
Profit Before Tax	43.47	53.03	42.21	48.67	39.62
Profit After Tax	26.73	38.88	33.39	34.98	29.87
Operating Profit after Depreciation	54.36	62.94	52.04	58.15	64.88

Particulars (in ₹ Cr.)	2025-03	2024-12	2024-09	2024-06	2024-03
Total Revenue	87.21	100.87	77.38	85.96	92.40
Total Expenses	73.04	78.81	63.86	65.04	63.16
Profit Before Tax	15.51	20.54	12.32	72.16	10.38
Profit After Tax	11.05	15.18	9.13	67.06	3.14
Operating Profit after Depreciation	18.70	23.49	15.18	74.80	32.45

Advanced Enzyme Technologies Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 334.13

S2 330.02

S3 324.83

Pivot 339.32

R1 343.43

R2 348.62

R3 352.73

Moving Average

20 SMA 328.92

50 SMA 307.40

100 SMA 297.94

200 SMA 353.97

Advanced Enzyme Technologies Ltd Corporate Actions

Advanced Enzyme Technologies Ltd

₹4.0/Share

Announcement Date 16 May 2025

Record Date 17 May 2025

Div Yield 200%

AGM Date: 19 Aug 2022

AGM 19/08/2022 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (as amended) read with Schedule III of the SEBI Listing Regulations, and in furtherance to our letter dated July 21, 2022 intimating about the 33rd Annual General Meeting of the Company ('AGM'), please find enclosed the Notice of 33rd AGM of the Company scheduled to be held on Friday, August 19, 2022 at 10:00 a.m. (IST) through Video Conference ('VC') or Other Audio Visual Means ('OAVM'), which is also being sent by electronic mode to the Members of the Company. The aforesaid Notice of 33rd AGM is also uploaded on the website of the Company (As Per BSE Announcement Dated on 27.07.2022) CORRIGENDUM - NOTICE OF THE 33RD ANNUAL GENERAL MEETING OF ADVANCED ENZYME TECHNOLOGIES LIMITED (As Per BSE Announcement Dated on 30/07/2022) Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 details regarding the voting results, based on the Scrutinizers report dated August 19, 2022 is enclosed. Also, Consolidated Scrutinizer Report dated August 19, 2022 on remote e-voting and electronic voting during the AGM is enclosed. Advanced Enzyme Technologies Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 20.08.2022)

AGM Date: 12 Aug 2023

Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 , it is hereby informed that Record Date has been fixed as Saturday, August 05, 2023, for the purpose of ascertaining the entitlement of the Members to the final dividend for FY 2023, if approved(declared) at the 34th AGM 34th Annual General Meeting of the Company will be held on Saturday, August 12, 2023, through Video Conference/ Other Audio Visual Means ( VC/OAVM) Notice of 34th AGM of the Company Scheduled to be held on Saturday, August 12, 2023 at 3:00 p.m. (IST) through Video Conference ('VC') or Other Audio Visual Means ('OAVM') (As Per BSE Announcement dated on 13.07.2023) Newspaper Publication informing the members inter-alia regarding the 34th AGM of the Company, Annual Report for financial year 2022-23 and the AGM notice sent by electronic mode(email). (As Per BSE Announcement Dated on 14.07.2023) Proceedings of 34th Annual General Meeting held on August 12, 2023. (As per BSE Announcement Dated on 12/08/2023)

AGM Date: 25 Jul 2024

This is to inform that the 35th Annual General Meeting of the Company will be held on Thursday, July 25, 2024. Record Date has been fixed as Thursday July 18, 2024 for the purpose of ascertaining the entitlement of the members to the Final Dividend for FY24, if approved (declared) at the 35th AGM. Notice of 35th Annual General Meeting of the Company (As Per BSE Announcement dated on 01.07.2024) Proceedings of 35th Annual General Meeting (AGM) held on July 25, 2024 Consolidated report of the Scrutinizer and details regarding voting results of 35th Annual General Meeting of the Company held on July 25, 2024 (As Per BSE Announcement Dated on: 25/07/2024)

AGM Date: 30 Jul 2025

The 36 th Annual general Meeting of the Company will be held on July 30 , 2025 Please find enclosed herewith Notice of the 36th Annual General Meeting of the Company. (As Per BSE Announcement dated on 03.07.2025) Please find enclosed herewith copies of Newspaper publication with respect to the completion of dispatch of Notice and Integrated Annual report for FY 2024-2025. (As Per BSE Announcement Dated on: 04.07.2025)

Advanced Enzyme Technologies Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,679.80	₹4,03,040.29
Divis Laboratories Ltd	₹6,883	₹1,82,722.02
Cipla Ltd	₹1,510.85	₹1,22,032.54
Torrent Pharmaceuticals Ltd	₹3,350.60	₹1,13,394.44
Dr Reddys Laboratories Ltd	₹1,310.05	₹1,09,334.39

Advanced Enzyme Technologies Ltd Top Mutal Funds Invested

Fund Name	AUM
ICICI Pru ESG Exclusionary Strategy Fund	1.74%
ICICI Pru P.H.D Fund	1.42%
UTI-MNC Fund	1.16%
Bank of India Small Cap Fund	0.60%
Bank of India ELSS Tax Saver	0.57%

Advanced Enzyme Technologies Ltd News

Advanced Enzyme Techs. to convene AGM

On 30 July 2025

13 May 2025, 05:04 pm

Board of Advanced Enzyme Techs. recommends interim dividend

Of Rs 4 per share

13 May 2025, 02:29 pm

Board of Advanced Enzyme Techs. recommends final dividend

Of Rs 1.2 per share

13 May 2025, 02:29 pm

Advanced Enzyme Techs. to declare Quarterly Results

On 13 May 2025

08 May 2025, 11:18 am

Advanced Enzyme Techs. to declare Quarterly Results

On 13 May 2025

07 May 2025, 11:26 am

Advanced Enzyme Technologies Ltd Stock Analysis

Annual revenue for Advanced Enzyme Technologies Ltd decreased by 2.68% to ₹412.90 crore in FY 2025 from ₹424.28 crore in FY 2024.
Annual Net Profit for Advanced Enzyme Technologies Ltd decreased by 5.27% to ₹102.42 crore in FY 2025 from ₹108.12 crore in FY 2024.
Promoter Shareholding in Advanced Enzyme Technologies Ltd increased by 0.36% in the most recent quarter, from 42.93% in December 2024 to 43.08% in March 2025.
Advanced Enzyme Technologies Ltd delivered a 1-year return of -13.53% compared to the Nifty 50, which provided a return of 4.69% as of the last trading session.
Advanced Enzyme Technologies Ltd share price moved down by 0.15% from its previous close of INR ₹338.25. The latest Advanced Enzyme Technologies Ltd share price is INR ₹337.75.
Advanced Enzyme Technologies Ltd share price today has been at a low of 331.05 and a high of 345.15. Over the past 52 weeks, the Advanced Enzyme Technologies Ltd share price has seen a low of 257.90 and a high of 571.